June 11th 2025
Compared with penicillin, investigators reported no significant differences in the incidence of ophthalmologic manifestations among patients treated with ceftriaxone.
Eye Care Symposia in Los Angeles
April 25-26, 2025
Register Now!
Community Practice Connections™: Optimizing Outcomes in Glaucoma Management - Applying Evidence to Practice with a Multitude of Treatment Options (CME Track)
View More
Community Practice Connections™: Mastering the New Treatment Paradigm in Geographic Atrophy – From Detection to Intervention (CME Track)
View More
Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics (CME Track)
View More
Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics (COPE Track)
View More
Community Practice Connections™: Mastering the New Treatment Paradigm in Geographic Atrophy – From Detection to Intervention (COPE Track)
View More
Surv.AI Says: Real-World Insights Into Patient Burden & Evolving Strategies in nAMD and DME (CME Credit)
View More
Surv.AI Says: Real-World Insights into Patient Burden & Evolving Strategies in nAMD and DME (COPE Credit)
View More
Assessing the Evidence for Extending Treatment Intervals in nAMD and DME Management – Expert Insights into Innovative Approaches (CME Track)
View More
Assessing the Evidence for Extending Treatment Intervals in nAMD and DME Management – Expert Insights into Innovative Approaches (COPE Track)
View More
Community Practice Connections™: Optimizing Outcomes in Glaucoma Management - Applying Evidence to Practice with a Multitude of Treatment Options (COPE Track)
View More
Reimagining Dry Eye Disease: Delineating the Role of Evaporation From Inflammation and Insights Into Optimizing Treatment (CME Track)
View More
Reimagining Dry Eye Disease: Delineating the Role of Evaporation From Inflammation and Insights Into Optimizing Treatment (COPE Track)
View More
19th Annual Controversies in Modern Eye Care
May 4, 2025
Register Now!
(CME Track) Community Practice Connections™: Advancing the Optimal Diagnosis & Treatment of Thyroid Eye Disease
View More
(COPE Track) Community Practice Connections™: Advancing the Optimal Diagnosis & Treatment of Thyroid Eye Disease
View More
(CME) Community Practice Connections™: A Closer Look at Neurotrophic Keratitis—Ensuring Timely Diagnosis and Taking Early Action
View More
Outlining the New Standard in Geographic Atrophy: Optimizing Care Within the Modern Treatment Paradigm (CME Track)
View More
Outlining the New Standard in Geographic Atrophy: Optimizing Care Within the Modern Treatment Paradigm (COPE Track)
View More
Collaborative Care Symposium
May 30-31, 2025
Register Now!
Community Practice Connections™: Novel Therapies for Neovascular Retinal Disease – Expert Analysis of New Key Data
View More
Practical Approaches to Modern Dry Eye Treatment and Management
June 25, 2025
Register Now!
Latest Advances in X-Linked Retinitis Pigmentosa: Optimizing Diagnosis and Developments in Gene Therapy
View More
Cases & Conversations™: Real World Review of Treat and Extend Strategies for Neovascular Retinal Disease
View More
Community Practice Connections™: Innovations and Interdisciplinary Approaches in Glaucoma Management—Expanding the Treatment Arsenal (CME Track)
View More
Community Practice Connections™: Innovations and Interdisciplinary Approaches in Glaucoma Management—Expanding the Treatment Arsenal (COPE Track)
View More
Road Mapping the Treat-and-Extend Protocol in nAMD and DME – When Time Is Sight (CME Track)
View More
Road Mapping the Treat-and-Extend Protocol in nAMD and DME – When Time Is Sight (COPE Track)
View More
Community Practice Connections™: Navigating Complexities in Neurotrophic Keratitis — A Roadmap for Advanced Patient Care (CME Credit)
View More
Community Practice Connections™: Navigating Complexities in Neurotrophic Keratitis — A Roadmap for Advanced Patient Care (COPE Credit)
View More
Causes of childhood blindness changing
October 16th 2005The patterns of childhood blindness and visual impairment are changing over time, according to Clare Gilbert, MD, MSc. Dr. Gilbert described the shifts in pediatric blindness patterns resulting from the ?nurture? factors Sunday at the American Academy of Ophthalmology annual meeting.
Read More
Refractive surgery an option for kids with high bilateral myopia
October 15th 2005Orlando—Refractive surgery may be an option for treating children with high myopia and neurobehavioral disorders who are unable to use either of the two principal methods of correcting myopia, spectacles or contact lenses.
Read More
Refractec promotes Frinzi to chief operating officer
October 14th 2005Refractec Inc. announces the promotion of Thomas G. Frinzi to the newly created position of chief operating officer to oversee the company?s growing global operations. Frinzi, formerly senior vice president of sales and marketing, will add clinical, regulatory affairs, and quality assurance to his sales and marketing responsibilities. He continues to report directly to President and CEO Mitchell B. Campbell.
Read More
Dry eye a constantly changing landscape
September 1st 2005Washington, DC-Dry eye disease affects millions of people worldwide and with that has come a recent greater awareness among patients that it is indeed a problem. As the recognition of the magnitude of dry eye is changing, so too has knowledge of its pathogenesis, the technology facilitating diagnosis, and the drugs that are becoming available to treat it. General ophthalmologists will be increasingly challenged to learn more about the disease and the best ways to treat individual patients, according to Michael Lemp, MD.
Read More
High-frequency UBM helpful tool in strabismus reoperation
September 1st 2005Orlando—The high-frequency ultrasound biomicroscope (UBM) can reliably estimate the distance of horizontal muscle insertion from the limbus in eyes that had previous strabismus surgery on the same muscle, according to Shuan H. Dai, MB, BS, FRANZCO, a pediatric ophthalmologist.
Read More
AAPOS backs pediatric screening
July 15th 2005Orlando—Ongoing efforts to encourage the adoption of mandatory preschool vision screening in every state were the main topic of discussion during a workshop at the annual meeting of the American Academy of Pediatric Ophthalmology and Strabismus (AAPOS).
Read More
Pediatric eye specialist honored at meeting
May 15th 2005Orlando—The American Association for Pediatric Ophthalmology and Strabismus recently honored Leonard Apt, MD, professor of ophthalmology and founding director of the division of pediatric ophthalmology at the Jules Stein Eye Institute at UCLA, at the group's annual meeting here.
Read More
Atropine treatment of moderate amblyopia assessed
April 1st 2005Baltimore—Prescribed weekend atropine sulfate 1% appears to be as effective as prescribed daily use for treating moderate amblyopia in young children, according to results from a study conducted by the Pediatric Eye Disease Investigator Group.
Read More
Transitions offers initiatives for success
March 15th 2005Orlando—Transitions Optical is offering new point-of-sale tools that allow eye-care professionals to add a personal touch to their discussion of healthy vision with patients. More than half of the materials now offered are customizable using the Transitions Online Marketing (TOM) tool.
Read More
J&J increases Definity lenses distribution
March 15th 2005Atlanta—Robertson Optical Laboratories, which operates wholesale lab branches in Georgia and South Carolina, has been selected as one of two wholesale lab companies to be authorized distributors of Definity lenses by manufacturer Johnson & Johnson.
Read More
TTT stabilizes vision in advanced AMD-related CNV
March 15th 2005Coronado, CA—Transpupillary thermotherapy (TTT) alone and combined with a single pretreatment intravitreal injection of triamcinolone acetonide 4 mg are similarly associated with vision stabilization over a 6-month follow-up period in eyes with large complicated choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD), reported Jans Fromow-Guerra, MD, PhD, at the annual meeting of the American Society of Retinal Specialists.
Read More
Corticosteroids may benefit pediatric orbital cellulitis
March 15th 2005Houston—Use of intravenous corticosteroids in the acute management of pediatric orbital cellulitis with subperiosteal abscess did not have an adverse effect on clinical outcomes and may be beneficial, according to Michael T. Yen, MD.
Read More